Essential Role of AT 1A Receptor in the Development of 2K1C Hypertension
- 1 November 2002
- journal article
- research article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 40 (5) , 735-741
- https://doi.org/10.1161/01.hyp.0000036452.28493.74
Abstract
The aims of this study were to delineate the relative contribution of angiotensin II (ANG II) subtype 1A (AT 1A ) and 1B (AT 1B ) receptors to the development of two-kidney, one-clip (2K1C) Goldblatt hypertension in mice, to examine if increased nitric oxide synthase (NOS) activity counteracts the vasoconstrictor influences of ANG II in 2K1C hypertensive mice, and to determine the role of ANG II type 2 (AT 2 ) receptors in 2K1C hypertension in mice. AT 1A ANG II receptor knockout (AT 1A −/−) and wild-type (AT 1A +/+) mice underwent clipping of the right renal artery. Systolic blood pressure (SBP) was significantly lower in AT 1A −/− compared with AT 1A +/+ mice, and neither clip placement nor AT 2 receptor blockade with PD 123319 (PD) altered SBP in AT 1A −/− mice. A significant and sustained rise in SBP from 119±5 to 163±6 mm Hg was observed in the 2K1C AT 1A +/+ mice from day 10 to day 26. Chronic PD infusion did not alter the course of hypertension in 2K1C/AT 1A +/+. Acute PD infusion did not alter mean arterial pressure (MAP) in AT 1A +/+, PD/AT 1A +/+, 2K1C/AT 1A +/+, PD/2K1C/AT 1A +/+, AT 1A −/−, PD/AT 1A −/−, and PD/2K1C/AT 1A −/− mice compared with basal levels. In contrast, acute PD infusion caused significant increases in MAP in 2K1C/AT 1A −/− mice. The subsequent acute NOS inhibition caused greater increases in MAP in 2K1C/AT 1A +/+ and PD/2K1C/AT 1A +/+ mice than in AT 1A +/+ and PD/AT 1A +/+ mice. These results support the essential role of AT 1A receptors in mediating 2K1C hypertension and support the hypothesis that augmented NO production serves as a counteracting system in this model of hypertension.Keywords
This publication has 19 references indexed in Scilit:
- Angiotensin II type 2 receptors: signalling and pathophysiological roleCurrent Opinion in Nephrology and Hypertension, 2001
- EFFECT OF NITRIC OXIDE INHIBITION ON KIDNEY FUNCTION IN EXPERIMENTAL RENOVASCULAR HYPERTENSIONClinical and Experimental Hypertension, 2001
- Nitric oxide: a physiological mediator of the type 2 (AT2) angiotensin receptorActa Physiologica Scandinavica, 2000
- No vasoactive role of the angiotensin II type 2 receptor in normotensive Wistar ratsJournal Of Hypertension, 1999
- Renal function in the AT1A receptor knockout mouse during normal and volume-expanded conditionsKidney International, 1999
- Angiotensin-II stimulates nitric oxide release in isolated perfused renal resistance arteriesPflügers Archiv - European Journal of Physiology, 1998
- Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure.Journal of Clinical Investigation, 1996
- Regulation of blood pressure by the type 1A angiotensin II receptor gene.Proceedings of the National Academy of Sciences, 1995
- Renal actions of the angiotensin AT2 receptor ligands CGP 42112 and PD 123319 after blockade of the renin-angiotensin systemEuropean Journal of Pharmacology, 1994
- Cloning, characterization, and expression of two angiotensin receptor (AT-1) isoforms from the mouse genomeBiochemical and Biophysical Research Communications, 1992